Amicus Piggybacks Off Galafold Commercial Infrastructure For Pombiliti + Opfolda Launch

 
• By Alaric DeArment
The FDA approved Amicus's Pombiliti + Opfolda in late-onset Pompe disease • Source: Shutterstock

More from New Products

More from Scrip